SGCIA
DGX icon

Smith Graham & Co Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-42,857
Closed -$2.65M – 134
2013
Q3 		$2.65M Sell
42,857
-500
-1% -$29.9K 0.38% 118
2013
Q2 		$2.63M Buy
+43,357
New +$2.58M 0.41% 110

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Smith Graham & Co Investment Advisors's DGX Position: Q4 2013 in Review

Smith Graham & Co Investment Advisors sold out of Quest Diagnostics (DGX) in Q4 2013, closing a stake of 42,857 shares — an estimated $2.65M sold.

Smith Graham & Co Investment Advisors first reported a position in DGX in Q2 2013 and held it in 2 quarters. The position peaked at $2.65M in Q3 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

  • Smith Graham & Co Investment Advisors reported no remaining Quest Diagnostics position as of Q4 2013 after selling out during the quarter.
  • Smith Graham & Co Investment Advisors sold 42,857 Quest Diagnostics shares in Q4 2013, an estimated $2.65M.
  • Smith Graham & Co Investment Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 2 quarters.
  • Smith Graham & Co Investment Advisors's Quest Diagnostics position peaked at $2.65M in Q3 2013.
  • 455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2013, filed 30 Jan 2014.